Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2010

01.04.2010 | Article

Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples

verfasst von: D. Stark, J. Barratt, T. Roberts, D. Marriott, J. Harkness, J. Ellis

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Dientamoeba fragilis is a pathogenic protozoan parasite that is notoriously difficult to diagnose. The aim of this study was to determine the gold standard for laboratory detection of D. fragilis. A total of 650 human faecal samples were included in the study. All specimens underwent the following: microscopy using a permanent stain (modified iron-haematoxylin), culture using a modified Boeck and Drbohlav’s medium (MBD) and TYGM-9, a conventional polymerase chain reaction (PCR) and a real-time PCR (RT-PCR). The overall prevalence of D. fragilis in the study population was 5.4% (35/650). RT-PCR detected 35 isolates, conventional PCR detected 15 isolates, MBD culture detected 14 isolates, TYGM-9 detected ten isolates, while microscopy detected 12 isolates. RT-PCR detected an additional 15 positive samples compared to the other diagnostic methods, all of which were confirmed by sequencing. When all methods were compared to each other, RT-PCR showed a sensitivity and specificity of 100 and 100%, conventional PCR 42.9 and 100%, MBD culture 40 and 100%, TYGM-9 culture 28.6 and 100%, and microscopy 34.3 and 99%, respectively. These results show that RT-PCR is the diagnostic method of choice for the detection of D. fragilis in clinical samples and, as such, should be considered as the gold standard for diagnosis.
Literatur
1.
Zurück zum Zitat Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2005) Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 43(6):2718–2723CrossRefPubMed Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2005) Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 43(6):2718–2723CrossRefPubMed
2.
Zurück zum Zitat Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2007) Dientamoeba fragilis as a cause of travelers’ diarrhea: report of seven cases. J Travel Med 14(1):72–73CrossRefPubMed Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2007) Dientamoeba fragilis as a cause of travelers’ diarrhea: report of seven cases. J Travel Med 14(1):72–73CrossRefPubMed
3.
Zurück zum Zitat Stark DJ, Beebe N, Marriott D, Ellis JT, Harkness J (2006) Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 22(2):92–96CrossRefPubMed Stark DJ, Beebe N, Marriott D, Ellis JT, Harkness J (2006) Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 22(2):92–96CrossRefPubMed
4.
Zurück zum Zitat Stark D, Phillips O, Peckett D, Munro U, Marriott D, Harkness J, Ellis J (2008) Gorillas are a host for Dientamoeba fragilis: an update on the life cycle and host distribution. Vet Parasitol 151(1):21–26CrossRefPubMed Stark D, Phillips O, Peckett D, Munro U, Marriott D, Harkness J, Ellis J (2008) Gorillas are a host for Dientamoeba fragilis: an update on the life cycle and host distribution. Vet Parasitol 151(1):21–26CrossRefPubMed
5.
Zurück zum Zitat Crotti D, D’Annibale ML, Fonzo G, Lalle M, Cacciò SM, Pozio E (2005) Dientamoeba fragilis is more prevalent than Giardia duodenalis in children and adults attending a day care centre in Central Italy. Parasite 12(2):165–170PubMed Crotti D, D’Annibale ML, Fonzo G, Lalle M, Cacciò SM, Pozio E (2005) Dientamoeba fragilis is more prevalent than Giardia duodenalis in children and adults attending a day care centre in Central Italy. Parasite 12(2):165–170PubMed
6.
Zurück zum Zitat Walker JC, Bahr G, Ehl AS (1985) Gastrointestinal parasites in Sydney. Med J Aust 143(10):480PubMed Walker JC, Bahr G, Ehl AS (1985) Gastrointestinal parasites in Sydney. Med J Aust 143(10):480PubMed
7.
Zurück zum Zitat Dobell C (1940) Researches on the intestinal protozoa of monkeys and man. X. The life history of Dientamoeba fragilis: observations, experiments, and speculations. Parasitology 32:417–461CrossRef Dobell C (1940) Researches on the intestinal protozoa of monkeys and man. X. The life history of Dientamoeba fragilis: observations, experiments, and speculations. Parasitology 32:417–461CrossRef
8.
Zurück zum Zitat Windsor JJ, Johnson EH (1999) Dientamoeba fragilis: the unflagellated human flagellate. Br J Biomed Sci 56(4):293–306PubMed Windsor JJ, Johnson EH (1999) Dientamoeba fragilis: the unflagellated human flagellate. Br J Biomed Sci 56(4):293–306PubMed
9.
Zurück zum Zitat van Gool T, Weijts R, Lommerse E, Mank TG (2003) Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis 22(5):284–290PubMed van Gool T, Weijts R, Lommerse E, Mank TG (2003) Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis 22(5):284–290PubMed
10.
Zurück zum Zitat Sawangjaroen N, Luke R, Prociv P (1993) Diagnosis by faecal culture of Dientamoeba fragilis infections in Australian patients with diarrhoea. Trans R Soc Trop Med Hyg 87(2):163–165CrossRefPubMed Sawangjaroen N, Luke R, Prociv P (1993) Diagnosis by faecal culture of Dientamoeba fragilis infections in Australian patients with diarrhoea. Trans R Soc Trop Med Hyg 87(2):163–165CrossRefPubMed
11.
Zurück zum Zitat Windsor JJ, Macfarlane L, Hughes-Thapa G, Jones SK, Whiteside TM (2003) Detection of Dientamoeba fragilis by culture. Br J Biomed Sci 60(2):79–83PubMed Windsor JJ, Macfarlane L, Hughes-Thapa G, Jones SK, Whiteside TM (2003) Detection of Dientamoeba fragilis by culture. Br J Biomed Sci 60(2):79–83PubMed
12.
Zurück zum Zitat Clark CG, Diamond LS (2002) Methods for cultivation of luminal parasitic protists of clinical importance. Clin Microbiol Rev 15(3):329–341CrossRefPubMed Clark CG, Diamond LS (2002) Methods for cultivation of luminal parasitic protists of clinical importance. Clin Microbiol Rev 15(3):329–341CrossRefPubMed
13.
Zurück zum Zitat Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2006) Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens. J Clin Microbiol 44(1):232–235CrossRefPubMed Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2006) Evaluation of three diagnostic methods, including real-time PCR, for detection of Dientamoeba fragilis in stool specimens. J Clin Microbiol 44(1):232–235CrossRefPubMed
14.
Zurück zum Zitat Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2005) Detection of Dientamoeba fragilis in fresh stool specimens using PCR. Int J Parasitol 35(1):57–62CrossRefPubMed Stark D, Beebe N, Marriott D, Ellis J, Harkness J (2005) Detection of Dientamoeba fragilis in fresh stool specimens using PCR. Int J Parasitol 35(1):57–62CrossRefPubMed
15.
Zurück zum Zitat Peek R, Reedeker FR, van Gool T (2004) Direct amplification and genotyping of Dientamoeba fragilis from human stool specimens. J Clin Microbiol 42(2):631–635CrossRefPubMed Peek R, Reedeker FR, van Gool T (2004) Direct amplification and genotyping of Dientamoeba fragilis from human stool specimens. J Clin Microbiol 42(2):631–635CrossRefPubMed
16.
Zurück zum Zitat Verweij JJ, Mulder B, Poell B, van Middelkoop D, Brienen EA, van Lieshout L (2007) Real-time PCR for the detection of Dientamoeba fragilis in fecal samples. Mol Cell Probes 21(5–6):400–404CrossRefPubMed Verweij JJ, Mulder B, Poell B, van Middelkoop D, Brienen EA, van Lieshout L (2007) Real-time PCR for the detection of Dientamoeba fragilis in fecal samples. Mol Cell Probes 21(5–6):400–404CrossRefPubMed
17.
Zurück zum Zitat Chan FT, Guan MX, Mackenzie AM, Diaz-Mitoma F (1994) Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole. Antimicrob Agents Chemother 38(5):1157–1160PubMed Chan FT, Guan MX, Mackenzie AM, Diaz-Mitoma F (1994) Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole. Antimicrob Agents Chemother 38(5):1157–1160PubMed
18.
Zurück zum Zitat Rayan HZ, Ismail OA, El Gayar EK (2007) Prevalence and clinical features of Dientamoeba fragilis infections in patients suspected to have intestinal parasitic infection. J Egypt Soc Parasitol 37(2):599–608PubMed Rayan HZ, Ismail OA, El Gayar EK (2007) Prevalence and clinical features of Dientamoeba fragilis infections in patients suspected to have intestinal parasitic infection. J Egypt Soc Parasitol 37(2):599–608PubMed
19.
Zurück zum Zitat Vandenberg O, Souayah H, Mouchet F, Dediste A, van Gool T (2007) Treatment of Dientamoeba fragilis infection with paromomycin. Pediatr Infect Dis J 26(1):88–90CrossRefPubMed Vandenberg O, Souayah H, Mouchet F, Dediste A, van Gool T (2007) Treatment of Dientamoeba fragilis infection with paromomycin. Pediatr Infect Dis J 26(1):88–90CrossRefPubMed
20.
Zurück zum Zitat Kurt O, Girginkardeşler N, Balcioğlu IC, Ozbilgin A, Ok UZ (2008) A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect 14(6):601–604CrossRefPubMed Kurt O, Girginkardeşler N, Balcioğlu IC, Ozbilgin A, Ok UZ (2008) A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect 14(6):601–604CrossRefPubMed
21.
Zurück zum Zitat Hiatt RA, Markell EK, Ng E (1995) How many stool examinations are necessary to detect pathogenic intestinal protozoa? Am J Trop Med Hyg 53(1):36–39PubMed Hiatt RA, Markell EK, Ng E (1995) How many stool examinations are necessary to detect pathogenic intestinal protozoa? Am J Trop Med Hyg 53(1):36–39PubMed
22.
Zurück zum Zitat Johnson EH, Windsor JJ, Clark CG (2004) Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 17(3):553–570, table of contentsCrossRefPubMed Johnson EH, Windsor JJ, Clark CG (2004) Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 17(3):553–570, table of contentsCrossRefPubMed
Metadaten
Titel
Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples
verfasst von
D. Stark
J. Barratt
T. Roberts
D. Marriott
J. Harkness
J. Ellis
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0876-4

Weitere Artikel der Ausgabe 4/2010

European Journal of Clinical Microbiology & Infectious Diseases 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.